TICKERNOMICS Sign up
Last Update: 2023-12-23 06:06:22
Resverlogix Corp. ( RVX.TO ) https://www.resverlogix.com
0.05USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
Canada
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-49.21%
RVX.TO
SPY
30.72%
-93.19%
RVX.TO
SPY
112.82%
-97.64%
RVX.TO
SPY
201.04%
-89.23%
RVX.TO
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
14.26
14.16
0.09
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.10
172.01
-0.20
0.22
0.00
-3.26
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.5924
58.72
41.19
0.66
Other Earnings and Cash Flow Stats:
Resverlogix Corp. ( RVX.TO ) Net Income TTM ($MM) is -17.36
Resverlogix Corp. ( RVX.TO ) Operating Income TTM ($MM) is -4.75
Resverlogix Corp. ( RVX.TO ) Owners' Earnings Annual ($MM) is -11.87
Resverlogix Corp. ( RVX.TO ) Current Price to Owners' Earnings ratio is -2.33
Resverlogix Corp. ( RVX.TO ) EBITDA TTM ($MM) is -4.00
Resverlogix Corp. ( RVX.TO ) EBITDA Margin is 0.00%
Capital Allocation:
Resverlogix Corp. ( RVX.TO ) has paid 0.00 dividends per share and bought back -16.996615 million shares in the past 12 months
Resverlogix Corp. ( RVX.TO ) has reduced its debt by 12.324 million USD in the last 12 months
Capital Structure:
Resverlogix Corp. ( RVX.TO ) Interest-bearing Debt ($MM) as of last quarter is 0
Resverlogix Corp. ( RVX.TO ) Annual Working Capital Investments ($MM) are -3
Resverlogix Corp. ( RVX.TO ) Book Value ($MM) as of last quarter is -72
Resverlogix Corp. ( RVX.TO ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Resverlogix Corp. ( RVX.TO ) has 0 million in cash on hand as of last quarter
Resverlogix Corp. ( RVX.TO ) has 25 million of liabilities due within 12 months, and long term debt 6 as of last quarter
Resverlogix Corp. ( RVX.TO ) has 271 common shares outstanding as of last quarter
Resverlogix Corp. ( RVX.TO ) has 0 million USD of preferred stock value
Academic Scores:
Resverlogix Corp. ( RVX.TO ) Altman Z-Score is -87.77 as of last quarter
Resverlogix Corp. ( RVX.TO ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Resverlogix Corp. ( RVX.TO ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Resverlogix Corp. ( RVX.TO ) for the amount of $ on
43.57% of Resverlogix Corp. ( RVX.TO ) is held by insiders, and 0.00% is held by institutions
Resverlogix Corp. ( RVX.TO ) went public on 1970-01-01
Other Resverlogix Corp. ( RVX.TO ) financial metrics:
FCF:0.03
Unlevered Free Cash Flow:-7.59
EPS:-0.07
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:24.87
Beta:0.66
Buffet's Owners Earnings:-11.87
Price to Owner's Earnings:-2.33
About Resverlogix Corp. ( RVX.TO ) :
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.